CVA: reducing the risk of a confused vascular analysis. The Feinberg lecture.
Furlan
A J
AJ
Department of Neurology, Cleveland Clinic, OH 44195, USA. furlana@ccf.org
D000925:Anticoagulants / Q000627:therapeutic use; D019090:Case Management; D002986:Clinical Trials as Topic / Q000379:methods; D003952:Diagnostic Imaging; D004334:Drug Administration Schedule; D004341:Drug Evaluation / Q000592:standards; D019317:Evidence-Based Medicine; D005104:Expert Testimony; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D010808:Physical Examination; D010820:Physicians / Q000523:psychology; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D012307:Risk Factors; D020521:Stroke / Q000145:classification / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D015912:Thrombolytic Therapy; D013997:Time Factors; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin